Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)

China · Delayed Price · Currency is CNY

20.43

-0.31 (-1.49%)

May 20, 2026, 11:34 AM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Commercial	888.77M	-	-	-	-
Manufacturing	4.99B	-	-	-	-
Others	144.21M	-	-	-	-
Intersegment Offset	-111.44M	-	-	-	-
Total	5.91B	-	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	5.85B	5.61B	4.97B	4.24B	3.90B
China Growth	4.24%	13.04%	17.18%	8.78%	17.33%
Foreign	23.30M	23.29M	8.87M	16.42M	22.80M
Foreign Growth	0.04%	162.53%	-46.00%	-27.97%	-2.65%
Unallocated	35.12M	59.61M	65.63M	43.49M	16.53M
Unallocated Growth	-41.08%	-9.19%	50.93%	163.08%	-2.73%
Total	5.91B	5.70B	5.04B	4.30B	3.94B
Total Growth	3.75%	13.01%	17.28%	9.22%	17.09%

Source: S&P Global Market Intelligence.